Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent DevelopmentsGlobeNewsWire • 03/13/23
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2023 After Market Close on March 13, 2023GlobeNewsWire • 03/06/23
Avid Bioservices: Production Expansion Capex And High Costs Are Temporary IssuesSeeking Alpha • 12/09/22
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2022 and Recent DevelopmentsGlobeNewsWire • 12/06/22
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022GlobeNewsWire • 11/29/22
Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare ConferenceGlobeNewsWire • 11/02/22
Does Avid Bioservices (CDMO) Have the Potential to Rally 61% as Wall Street Analysts Expect?Zacks Investment Research • 10/17/22
Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare ConferenceGlobeNewsWire • 09/07/22
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent DevelopmentsGlobeNewsWire • 09/06/22
Avid Bioservices Appoints Pramthesh (Prem) Patel, Ph.D., as Vice President, Process Development for Mammalian Cell BusinessGlobeNewsWire • 09/01/22
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2023 After Market Close on September 6, 2022GlobeNewsWire • 08/30/22
Avid Bioservices, Inc. (CDMO) CEO Nick Green on Q4 2022 Results - Earnings Call TranscriptSeeking Alpha • 06/30/22
Avid Bioservices Reports Financial Results for Fourth Quarter and Full Fiscal Year Ended April 30, 2022 and Recent DevelopmentsGlobeNewsWire • 06/29/22